Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
BRIEF CURRICULUM VITAE (09-15-2013) Name: Jeon-Hor Chen, M.D. Titles/Affiliations: 1. Associate Researcher (equivalent to Associate Professor), Center for Functional Onco-Imaging, University of California Irvine, California, USA 2. Honorary Professor, Department of Radiology, Eda Hospital and I-Shou University, Kaoshiung, Taiwan Address: Center for Functional Onco-Imaging, University of California Irvine, No 164, Irvine Hall, CA 92697 Telephone: 949-8249327 Fax: 949-8243481 e-mail: [email protected] A. Education Year 1979-1986 Institution Degree National Yang-Ming Medical University, Taipei, TAIWAN. M.D. B. Professional Experience 1984.7-1986.6 Medical Internship, Veteran General Hospital, Taipei, Taiwan. 1986.9-1988.8 Military Service, Lieutenant Officer 1 1988.9 – 1993.8 Resident and Fellow, Department of Radiology, Taichung Veterans General Hospital 1993 ~ 1998 Staff Physician, Department of Radiology, Taichung VGH 1995~1996 Visiting scholar in Department of Radiology, Hospital of University of Technology in Aachen, (10 months), Department of Radiology, Hospital of University of Bonn, (2 weeks), Department of Radiology, Hospital of University of Tubingen, (1 week), and Department of Radiology, Hospital of University of Berlin, Germany (2 weeks) 1999 ~ 2002 Assistant Professor of Diagnostic Radiology and Institute of Medical Research, China Medical University, Taichung, Taiwan 1998 ~ 2003 Staff Physician, Department of Radiology, China Medical College Hospital, 1999 ~ 2005 Head, Department of Radiology, China Medical University, Taichung, Taiwan 2003 ~ 2005 Chief, Section of GI Radiology, Department of Radiology, China Medical College Hospital, Taichung, Taiwan 2003 ~ 2007 Associate Professor of Diagnostic Radiology and Institute of Medical Research, China Medical University, Taichung, Taiwan 1999 ~ 2005 Executive Editor, Mid-Taiwan Journal of Medicine, Taichung, Taiwan 2005 ~ 2007 Visiting Associate Researcher, Center for Functional Onco-Imaging, University of California Irvine, California, USA 2008 ~ 2012 Professor of Diagnostic Radiology and Institute of Medical Research, China Medical University, Taichung, Taiwan 2009-2011 Chief, Section of Medical Imaging Research, Department of Radiology, China Medical College Hospital, Taichung, Taiwan 2008 ~ present Associate Researcher (equivalent to Associate Professor), Center for Functional Onco-Imaging, University of California Irvine, California, USA 2013 ~ present Honorary Professor, Department of Radiology, Eda Hospital and I-Shou University, Kaoshiung, Taiwan C. Honors and Awards 2001 Fellowship Grant, Research and Education Fund, European Congress of Radiology, 2 Vienna, Austria 2004 Physician Scientist Award, National Health Research Institute (NHRI), Taiwan 2008 Faculty development award, Department of Radiology, UC Irvine Medical Center 2008 Distinguished Researcher Award, China Medical University, Taichung, Taiwan -2011 D. Ongoing Grant Supports NIH/NCI 1 R01 CA127927 (Co-investigator) 04/01/13 – 03/31/18 Predicting Neoadjuvant Chemo Response/Prognosis Using Imaging Biomarkers This study will use MRI and SMM markers to investigate and compare the response of patients with breast cancer to neoadjuvant chemotherapy. The diagnostic results obtained using MRI and SMM from tumors of varying stages at different times during NAC will provide very important information for establishing the role of a standalone SMM system for management of breast cancer, including screening and diagnosis. NIH/NCI R21 CA170955 (Principal investigator) 01/01/2013 – 12/31/2014 Volume and Morphology of Fibroglandular Tissue for Breast Cancer Risk Prediction This study will evaluate the role of MRI-based density parameters, including the volume and the morphology of the fibroglandular tissue, and build a risk prediction model using a case-control study design. 101-2314-B-039-034- (Principal investigator) National Science Council (NSC), Taiwan Multi-Modalities Quantitative Imaging Study of the Breast 08/01/12 – 10/31/13 E. Professional Activities Society membership: 1. Radiological Society of North America (RSNA) 2. International Society of Magnetic Resonance in Medicine (ISMRM) 3. European Society of Radiology (ESR) 4. Radiological Society of Republic of China (RSROC) Editorial Board: 1. Advances in Breast Cancer Research 3 2. Experimental Hematology and Oncology 3. Modern Chemotherapy 4. Journal of Computational Medicine 5. OA Translational Research 6. Journal of Radiology & Radiation Therapy 7. Radiology: Open Access 8. International Scholarly Research Network (ISRN) Radiology 9. The Journal of Radiology Case Reports 10. Research and Reports in Focused Ultrasound Referee NIH/NCI (USA); Annals of Oncology; Cancer; Neoplasia; Breast Cancer Research and Treatment; British J Cancer; BMC Cancer; PloS One; Molecular Imaging and Biology; Journal of the American Medical Informatics Association, NMR in Biomedicine; ISMRM; J. Magnetic Resonance Imaging; European Radiology; European Journal of Radiology; Clinical Medicine: Oncology; BMC Medical Imaging; Mid-Taiwan Journal of Medicine; Chinese Journal of Radiology; National Science Council, Taiwan; Willy Gepts Research Foundation (UZ Brussel),The Journal of Diabetes and Its Complications; Frontier in Medicine; Journal of Radiology Case Reports; Radiology Open Access; Modern Chemotherapy F. Publications: Original Peer-Reviewed Articles: ***Total impact factor score for papers of first author and corresponding author in recent 5 years: >120 115. Chen JH, Yu H, Lin M, Mehta RS, Su MY. Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI. Magn Reson Imaging. 2013 Aug 28. 114. Yang MC, Moon WK, Wang YC, Bae MS, Huang CS, Chen JH, Chang RF. Robust Texture Analysis Using Multi-resolution Gray-scale Invariant Features for Breast Sonographic Tumor Diagnosis. IEEE Trans Med Imaging. 2013 Aug 29. [Epub ahead of print] 113. Chen JH, Su MY. Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy. Biomed Res Int. 2013;2013:348167. 112. Chen JH, Pan WF, Kao J, Lu J, Chen LK, Kuo CC, Chang CK, Chen WP, McLaren CE, Bahri S, Mehta RS, Su MY. Effect of Taxane-Based Neoadjuvant Chemotherapy on Fibroglandular 4 Tissue Volume and Percent Breast Density in the Contralateral Normal Breast: Evaluated at 3T MR. NMR in Biomedicine. 2013 Aug 12. 111. Moon WK, Lo CM, Cho N, Chang JM, Huang CS, Chen JH, Chang RF. Computer-aided diagnosis of breast masses using quantified BI-RADS findings. Comput Methods Programs Biomed. 2013 Jul;111(1):84-92. 110. Liao YH, Lo YP, Chen JH*. Small cardiogastric tube fistula connecting to right atrium. The American Journal of Gastroenterology. Am J Gastroenterol 2013; 108:1398 109. Chen JH*, Chen WP, Chan S, Yeh DC, Su MY, McLaren CE. Correlation of Endogenous Hormonal Levels, Fibroglandular Tissue Volume and Percent Density Measured Using 3D MRI during one Menstrual Cycle. Annals of Oncology. Ann Oncol. 2013;24(9):2329-35. 108. Moon WK, Lo CM, Chang JM, Huang CS, Chen JH, Chang RF. Quantitative Ultrasound Analysis for Classification of BI-RADS Category 3 Breast Masses. J Digit Imaging. 2013 Mar 15. [Epub ahead of print] 107. O'Sullivan TD, Leproux A, Chen JH, Bahri S, Matlock A, Roblyer D, McLaren CE, Chen WP, Cerussi AE, Su MY, Tromberg BJ. Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy. Breast Cancer Res. 2013 Feb 22;15(1):R14. [Epub ahead of print] 106. Huang YH, Chen JH, Chang YC, Huang CS, Moon WK, Kuo WJ, Lai KJ, Chang RF. Diagnosis of Solid Breast Tumors Using Vessel Analysis in Three-Dimensional Power Doppler Ultrasound Images. J Digit Imaging. 2013 Aug;26(4):731-9. 105. Ho CY, Liao HM, Tu CY, Huang CY, Shih CM, Su MY, Chen JH*, Shih TC. Numerical analysis of airflow alteration in central airways following tracheobronchial stent placement. Exp Hematol Oncol. 2012 Aug 27;1(1):23. 104. Lin WC, Chen JH, Liao YS, Ho YJ. CT image in determining the need of TAE for management of blunt renal injury. J Trauma and Acute Care Surgery 2013 Jan;74(1):230-5. 103. Moon WK, Huang CS, Chen JH, Chang RF. Computer-aided Tumor Detection Based on Multi-scale Blob Detection Algorithm in Automated Breast Ultrasound Images. IEEE Transactions on Medical Imaging 2013 Jul;32(7):1191-200. 102. Chen JH, Chan S, Yeh DC, Fwu, PT, Lin M, Min-Ying Su MY. Response of Bilateral Breasts to the Endogenous Hormonal Fluctuation in A Menstrual Cycle Evaluated Using 3D MRI. Magnetic Resonance Imaging 2013 May;31(4):538-44. 101. Moon WK, Lo CM, Chang JM, Huang CS, Chen JH, Chang RF. Computer-aided classification of breast masses using speckle features of automated breast ultrasound images. Med Phys. 2012 Oct;39(10):6465-73. 100. Yang MC, Huang CS, Chen JH, Chang RF. Whole Breast Lesion Detection Using NaiveBayes Classifier for Portable Ultrasound. Ultrasound Med Biol. Ultrasound Med Biol. 2012 Nov;38(11):1870-80. 99. Chen JH , Chan S, Liu YJ, Yeh DC, Chang CK, Chen LK, Pan WF, Kuo CC, Lin M, Chang D HE, Fwu PT, Su MY. Consistency of Breast Density Measured from the Same Women in Four Different MR Scanners. Medical Physics. 2012 Aug;39(8):4886-95. 98. Moon WK, Lo CM, Huang CS, Chen JH, Chang RF. Computer-aided diagnosis based on speckle patterns in ultrasound images. Ultrasound Med Biol. 2012 Jul;38(7):1251-61. 5 97. Kuzucan A, Chen JH*, Bahri S, Mehta RS, Carpenter PM, Fwu PT, Yu HJ, Hsiang DJ, Lane KT, Butler JA, Feig SA, Su MY. Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile. Clin Breast Cancer. 2012 Apr;12(2):110-8. 96. Cheng YC, Wu NY, Ko JS, Lin PW, Lin WC, Juang SJ, Tsai TT, Chang CY, Chen JH*, Cheng HC. Breast cancers detected by breast MRI screening and ultrasound in asymptomatic Asian women: 8 years of experience in Taiwan. Oncology. 2012;82(2):98-107. 95. Chang YC, Huang YH, Huang CS, Chang PK, Chen JH*, and Chang RF. Classification of breast mass lesions using model-based analysis of the characteristic kinetic curve derived from fuzzy c-means clustering. Magnetic Resonance Imaging. 2012 Apr;30(3):312-22. 94. Chan S, Chen JH, Agrawal G, Lin M, Mehta RS, Carpenter PM, Nalcioglu O, Su MY. Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features? J Oncol. J Oncol. 2010;2010. Epub 2010 Sep 21. 93. Chang DHE, Chen JH*, Lin MQ, Bahri S, Yu HJ, Mehta RS, Nie K, Hsiang D, Nalcioglu O, Su MY. Comparison of breast density measured on MR images acquired using fat-suppressed versus non-fat-suppressed sequences. Medical Physics. 2011;38(11):5961-8. 92. Chen JH, Chan S, Chang DHE, Lin MQ, Su MY. Consistency of Breast Density Measured from the Same Women Using Different MR Scanners. Annals of Oncology. 2011 Dec;22(12):2693-4. 91. Lin MQ, Chen JH, Mehta RS, Bahri S, Chan SW, Nalcioglu O, Su MY. Spatial Shrinkage/Expansion Patterns between Breast Density Measured in Two MRI Scans Evaluated by Non-rigid Registration. Physics in Medicine and Biology. 2011;56(18):5865-75. 90. Chen JH, Bahri S, Mehta RS, et al. Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Breast MRI at 3T. Radiology 2011 261(3):735-43. 89. Chan SW, Su MY, Lei FJ, Wu JP, Lin MQ, Nalcioglu O, Stephen F, Chen JH*. Menstrual cycle related fluctations in breast density measured by 3D MRI. Radiology. 2011;261(3):744-51. 88. Moon WK, Shen YW, Huang CS, Luo SC, Chen JH* , Chang RF. Comparative Study of Density Analysis Using Automated Whole Breast Ultrasound and MRI. Medical Physics. 2011 Jan;38(1):382-9. 87. Lin M, Chan S, Chen JH, Chang D, Nie K, Chen ST, Lin CJ, Shih TC, Orhan Nalcioglu O, Su MY. A New Bias Field Correction Method Combining N3 and FCM for Improved Segmentation of Breast Density on MRI. Medical Physics. 2011;38(1):5-14 86. J-H. Chen, R. S. Mehta, H-M. Baek, K. Nie, H. Liu, MQ Lin, H. J. Yu, O. Nalcioglu, M-Y. Su. Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MR spectroscopy. NMR Biomed. 2011;24(3):316-24. 85. JH Chen, YC Chang, D Chang, YT Wang, K Nie, RF Chang, O Nalcioglu, CS Huang, MY Su. Reduction of Breast Density Following Tamoxifen Treatment Evaluated by 3-D MRI: Preliminary Study. Magnetic Resonance Imaging. 2011 Jan;29(1):91-8. 84. Nie K, Su MY, Chau MK, Chan S, Nguyen H, Tseng T, Huang Y, McLaren CE, Nalcioglu O, Chen JH. Age- and race-dependence of the fibroglandular breast density analyzed on 3D MRI. Med Phys. 2010 Jun;37(6):2770-6. 6 83. Shih TC, Chen JH, Liu DX, Nie K, Sun LZ, Lin MQ, Chang D, Nalcioglu O, Su MY. Computational Simulation of Breast Compression Based on Segmented Breast and Fibroglandular Tissues on Magnetic Resonance Images. Physics in Medicine and Biology. 2010 Jul 21;55(14):4153-68. 82. Chen JH, Mehta RS, Nalcioglu O, Su MY. MR imaging evaluation of non-inflammatory breast cancer with skin involvement following neoadjuvant chemotherapy. Annuals of Surgical Oncology. 2010 Jul;17(7):1964-5. 81. Chang RF, Chang-Chien KC, Takada E, Huang CS, Chou YH, Kuo CM, Chen JH. Rapid Image Stitching and Computer-aided Detection for Multi-pass Automated Breast Ultrasound. Medical Physics. 2010 May;37(5):2063-73. 80. Nie K, Chen JH, Chang D, Hsu CC, Nalcioglu O, Su MY. Quantitative Analysis of Breast Parenchymal Patterns Using 3D Fibroglandular Tissue Segmentation Based on MRI. Medical Physics 2010;37(1):217-226 79. Nie K, Chang D, Chen JH, Hsu CC, Shih TC, Nalcioglu O, Su MY. Segmentation of Skin for Quantitative Measurement of Breast Density on MRI. Medical Physics 2010;37(1):227-233 77. Chen JH, Nie K, Bahri S, Hsu CC, Hsu FT, Shih HN, Lin MQ, Nalcioglu O, Su MY. MRI Evaluation of Decrease of Breast Density in the Contralateral Normal Breast of Patients Receiving Neoadjuvant Chemotherapy. Radiology 2010 Apr;255(1):44-52. 76. Baek HM, Chen JH, Nalcioglu O, Su MY. Can MR Spectroscopy Provide Useful Information for Characterizing Estrogen Receptor Status in Breast Cancer? In press, Annals of Oncology 2010 Mar;21(3):663-5. 75. Lin M, Chen JH, Ni K, Chang D, Nalcioglu O, Su MY. An Algorithm-Based Method for the Detection of Blood Vessels in Breast MRI for the Development of Computer-Aided Diagnosis. JMRI Oct;30(4):817-24. 74. Chen JH, Huang CS, Chang Chien KC, Takada E, Moon WK, Wu JHK, Cho N, Wang YF, Chang RF. Breast Density Analysis for Whole Breast Ultrasound Images. Medical Physics 2009 Nov;36(11):4933-43. 73. Newell D, Nie K, Chen JH, Hsu CC, Yu HJ, Nalcioglu O, Su MY. Selection of Diagnostic Features to Differentiate between Malignant and Benign Lesions that Presented as Mass and Non-Mass Lesions on Breast MRI. European Radiology 2010 Apr;20(4):771-81. 72. Chen JH, Chang D, Nie K, Hsu FT, Shih HN, Shu CC, Nalcioglu O, Su MY. Comparison of Breast Density in the Contralateral Normal Breast of Patients with Invasive and In-Situ Breast Cancer Measured on MRI. Annals of Oncology 2009 Aug;20(8):1449-50. 71. Chen JH, Hsu FT, Shih HN, Hsu CC, Chang D, Nie K, Nalcioglu O, Su MY. Does Breast Density Show Difference in Patients with Estrogen Receptor Positive and Estrogen Receptor Negative Breast Cancer Measured on MRI ? Annals of Oncology 2009 Aug;20(8):1447-9. 70. Lin CH, Chen JH, Li TC, Ho YJ, Lin WC. Children presenting at the emergency department with right lower abdominal pain. Kaohsiung J Med Sci 2009;25:1–9 69. Lin WC, Chen YF, Lin CH, Ho YJ, Tzeng YH, Chiang HJ, Chang CH, Cheng YC, Shen WC, Chen JH. Reappraisal of the management and outcome of emphysematous pyelonephritis. Kaohsiung J Med Sci 2009;25:16–24 68. Bahri S, Chen JH, Mehta RS, Carpenter PM, Nie K, Kwon SY, Yu HJ, Nalcioglu O, Su MY. Residual Breast Cancer Diagnosed by MRI in Patients Receiving Neoadjuvant 7 Chemotherapy with and without Bevacizumab. Annals of Surgical Oncology 2009 Jun;16(6):1619-28. 67. Lai HY, Chen JH, Chiu KM, Wan KL, Cheung WK, Li AH, Chu SH. CT imaging of two hearts beat in one chest. AJR 2008 Dec;191(6):1711-6 66. Chen JH, Mehta RS, Nalcioglu O, Su MY. Inflammatory Breast Cancer Following Neoadjuvant Chemotherapy: Can MR Imaging Precisely Diagnose the Pathological Response? Annals of Surgical Oncology 2008 Dec;15(12):3609-13. 65. Agrawal G, Su MY, Nalcioglu O, Stephen F, Chen JH. Significance of Breast Lesion Descriptors in the ACR BIRADS MRI Lexicon. Cancer 2009 Apr 1;115(7):1363-80. 64. Nie K, Chen JH, Chan S, Chau MK, Yu HJ, Bahri, S, Tseng T, Nalcioglu O, Su MY. Development of A Quantitative Method for Analysis of Breast Density Based on 3-Dimensional Breast MRI. Medical Physics 2008:35(12):5253-62. 63. Chen JH, Feig BA, Hsiang JB, Butler JA, Mehta RS, Bahri S, Nalcioglu O, Su MY. Impact of MRI-Evaluated Neoadjuvant Chemotherapy Response on Change of Surgical Recommendation in Breast Cancer. Annals of Surgery 2009 Mar;249(3):448-54. 62. Baek HM, Chen JH, Nie K, Yu HJ, Bahri S, Mehta RS, Nalcioglu O, Su MY. Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Using MRI and Quantitative Proton MR Spectroscopy. Radiology 2009 Jun;251(3):653-62. 61. Nie K, Chen JH, Yu HJ, Chu Y, Nalcioglu O, Su MY. Quantitative Analysis of Lesion Morphology and Texture Features for Diagnostic Prediction in Breast MRI. Academic Radiology 2008 Dec;15(12):1513-25.. 60. Chen JH, Naclioglu O, Su MY. Fibrocystic change presenting as a focal lesion mimicking breast cancer. JMRI 2008 Dec;28(6):1499-505. 59. Chen JH, Liu H, Baek, HM, Nalcioglu O, Su MY. MR imaging of fibrocystic change of the breast. Magnetic Resonance Imaging 2008 Nov;26(9):1207-14. 60. Ho TJ, Duann JR, Chen CM, Chen JH, Shen WC, Lu, TW, Liao JR, Lin JG. Carryover effects alter FMRI statistical analysis in an acupuncture study. Am J Chin Med. 2008;36 (1):55-70 57. Baek HM, Chen JH, Naclioglu O, Su MY. Proton MR spectroscopy for monitoring early treatment response of breast cancer to neoadjuvant chemotherapy. Annals of Oncology Ann Oncol. 2008 May;19(5):1022-4. 56. Chen JH, Nalcioglu O, Su MY. MR imaging of invasive breast cancer correlated with hormonal receptors: Does progesterone receptor matter ? Annals of Oncology 2008 May;19(5):1024-6. 55. Lin WC, Chen YF, Lin CH, Tzeng YH, Chiang HJ, Ho YJ, Shen WC, Chen JH. Emergent transcatheter arterial embolization in hemodynamically unstable patients with blunt splenic injury. Academic Radiology 2008;15(2):201-208 54. Bahri S, Chen JH, Yu HJ, Kuzucan A, Nalcioglu O, Su MY. Can Dynamic Contrast-Enhanced MRI (DCE-MRI) Predict tumor recurrence and lymph node status in patients with breast cancer? Annals of Oncology. 2008 Apr;19(4):822-4. 53. Baik HM, Chen JH, Nalcioglu O, Su MY. Choline as a biomarker for cell proliferation: do the results from proton MR spectroscopy show difference between HER2/neu positive and negative breast cancers? International J Cancer 2008 Sep;123(5):1219-21. 52. Chen JH, Baik HM, Nalcioglu O, Su MY. Estrogen receptor and breast MR imaging features: a correlation study. JMRI 2008 Apr;27(4):825-33 8 51. Baik HM, Yu HJ, Chen JH, Nalcioglu O, Su MY. Correlation between choline and contrast enhancement in human breast cancer measured by quantitative 1H single-voxel MR spectroscopy and dynamic contrast enhanced MRI. Magnetic Resonance Imaging, 2008 May;26(4):523-31. 50. Agrawal G, Chen JH, Baik HM, Hsiang D, Mehta RS, Nalcioglu O, Su MY. MR imaging features of breast cancer: a correlation study with HER-2 receptor. Annals of Oncology, 2007 Nov;18(11):1903-4. 49. Chen JH, Mehta RS, Carpenter PM, Nalcioglu O, Su MY. MRI in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy. J Clin Oncol. 2007 Dec 10;25(35):5667-9 48. Chen JH, Agrawal G, Feig, B, Baik HM, Carpenter PM, Nalcioglu O, Su MY. Triple negative breast cancer: MR imaging features in 29 patients. Annals of Oncology, 2007 Dec;18(12):2042-3 47. Chen JH, Agrawal G, Carpenter PM, Mehta RS, Nalcioglu O, Su MY. Pathological axillary lymph node status in HER-2 receptor positive and negative breast cancers. Annals of Surgical Oncology, 2008 Mar;15(3):941-2 46. Chen JH, Feig B, Agrawal G, Yu H, Carpenter PM, Mehta PS, Nalcioglu O, Su MY. MRI evaluation of pathological complete response and residual tumors in breast cancer following neoadjuvant chemotherapy. Cancer. 2008;112:17-26 45. Lin WC, Chen JH. Urinary bladder metastasis from breast cancer with heterogeneic expression of estrogen and progesterone receptors. Journal of Clinical Oncology. 2007 September 20; 25(27):4308 - 4310 44. Lin WC, Chen JH, Lin CH, Shen WC. Rapidly progressive pancreatic lipomatosis in a young adult patient with transfusion-dependent myelodysplastic syndrome. J Formos Med Assoc. 2007 Aug;106(8):676-9. 43. Agrawal G, Chen JH, Baick CH, Chen A, Mehta RS, Nalcioglu O, Su MY. Pathological complete response in triple negative poorly differentiated invasive ductal carcinoma detected during pregnancy. Journal of Clinical Oncology. 2007; June 20 issue: 2618-2610 42. Yu H, Chen JH, Su MY, Mehta R, Nalcioglu O. MRI Measurements of Tumor Size and Pharmacokinetic Parameters as Early Predictor of Response in Breast Cancer Patients Undergoing Neoadjuvant AC-Chemotherapy. JMRI. 2007 Sep;26(3):615-23. 41. Baik HM,Chen JH, Su MY, Yu H, Mehta R, Nalcioglu O. Characterization of Human Breast Lesions with in Vivo MR Chemical-Shift Imaging. JMRI, 2008 May;27(5):1114-21 40. Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O. Comparison of Choline and Pharmacokinetic Parameters in Breast Cancer Measured by MR Spectroscopic Imaging and Dynamic Contrast Enhanced MRI. Technology in Cancer Res Treat. 2006;5:401-410. 39. Huang YL, Chen JH, Shen WC. Diagnosis of hepatic tumors with texture analysis in nonenhanced computed tomography images. Acad Radiol. 2006 Jun; 13(6):713-20. 35. Lin YC, Chen JH, Han KW, Shen WC. Ablation of Liver Tumor by Injection of Hypertonic Saline. Am. J. Roentgenol., Jan 2005; 184: 212 - 219. 32. Chen JH, Lin YC, Shen WJ. Implantation of VX2 tumor in rabbit liver: comparison of two inoculation methods. Lab Anim. 2004 Jan; 38(1):79-84. 9 30. Pan CT, Chou KJ, Chen JH, Jian IP, Lin JI, Tsai JH. Safety monitoring of cardiac and hepatic systems in -thalassemia patients with chelating treatment in Taiwan. Eur J. Haematol 2003 (June); 70:392-397 27. Lin WY, Chen JH, Lin YC, Han KW. Implantation of VX2 carcinoma into the liver of rabbits: a comparison of three direct-injection methods. J. Vet. Med. Sci. 2002; 64(7):649-652 26. Tsai JW, Chen JH, Chiang JM. SPGR as an arterial spin tagging technique for quick evaluation of local perfusion. JMRI 2002; 16: 51-59 24. Chen JH, Chai JW, Chu WC, Chiang JM, Shen WC. Free breathing Magnetic Resonance Cholangiopancreatography (MRCP) at end expiration: a new technique to expand clinical application. Hepato-Gastroenterology 2002; 49:593-596 23. Tsai PP, Chen JH, Huang JL, Shen WC. Dependent Pooling: A Contrast-Enhanced Sign of Cardiac Arrest During CT. Am. J. Roentgenol., May 2002; 178: 1095 - 1099. 22. Chai JW, Lin JC, Chen JH, Wu JC, Lee GP, Chu WC, Lee SK. In vivo Magnetic Resonance (MR) study of fatty liver: importance of intracellular ultrastructural alteration for MR tissue parameters change. Journal of Magnetic Resonance Imaging 2001; 14:35-41 17. Chen WP, Chen JH, Hwang JI, Tsai JW, Chen JS, Hung SW, Su YG, and Lee SK. Spectrum of transient hepatic attenuation differences in biphasic helical CT. Am. J. Roentgenol., Feb 1999; 172: 419 - 424. 16. Chen JH, Chai JW, Huang CL, Hung HC, Shen WC, Lee SK. Proximal arterioportal shunting associated with hepatocellular carcinoma: features revealed by dynamic helical CT. Am. J. Roentgenol., Feb 1999; 172: 403 - 407. 15. Chen JH, Chai JW, Lee SK, Yang HN. Evaluation of liver diseases with magnetization transfer and contrast agents. J Mag Reso Imag, 1999; 9(2):257-265 11. Chen JH, Chen WP, Hwang JL, Shen WC. Dynamic helical CT as a novel technique for evaluating hepatic perfusion disorders. Hepatogastroenterology, 1999; 46(25):303-307 9. Chen JH, Hwang JH, Hwang JI, Lee SK, Shen WC. Dynamic helical biphasic CT emerges as a potential technique for the diagnosis of proximal arterioportal shunting. Hepatogastroenterology, 1999; 46(27): 1791-1797 8. Chen JH, Chai JW, Shen WC. Magnetization transfer contrast imaging of liver cirrhosis. Hepatogastroenterology, 1999; 46(29):2872-2877 5. Chen JH, Katterbach FJ. Rotational phantom for evaluating MR biopsy needle artifacts. AJR 1997; 168:1383-1384 3. Chai JW, Chen CC, Chen JH, Lee SK, Yang HN. Estimation of in vivo proton intrinsic and cross-relaxation rates in human brain. Magn Reson Med 1996; 36(1): 147-152 2. Urhahn R, Adam G, Busch N, Chen JH, Euringer W, Guenther RW. Superparamagnetische eisenoxidpartikel: welchen stellenwert hat der T1-effekt fur die MR-diagnostik fokaler leberlasionen. ROFO 1996; 165(4): 364-370 (in German) 10 Books 1. Jeon-Hor Chen. Gradient echo sequences and fast MR imaging technique. In Diagnostic MR Imaging, published by Hwa-Jun publication company, 1989, Taipei 2. Jeon-Hor Chen. MRI of Great Vessels. In Diagnostic MR Imaging, published by Hwa-Jun publication company, 1989, Taipei 3. Jeon-Hor Chen. Basic principle of MR imaging. In Biomagnetic material and related technologies. Published by Society of Biomagnetic Material and Technology, 2003, Taipei 4. Jeon-Hor Chen. Quantitative Measurements of Tracer Transport Parameters Using Dynamic Contrast-Enhanced MRI as Vascular Perfusion and Permeability Indices in Cancer Imaging. In Quantifying Morphology and Physiology of the Human Body Using MRI. L . Tugan Muftuler. Taylor & Francis 2013. Print ISBN: 978-1-4398-5265-1. eBook ISBN: 978-1-4398-5268-2 Peer-Reviewed Conference Papers: more than 100 presented in imaging, surgery, and oncology conferences Examples of 5 abstracts. 1. Chen, Jeon-Hor; Bahri, Shadfar; Carpenter, P.; Yu, H-J; Mehta, R.; Nalcioglu, Orhan; Su, Min-Ying Lydia. Evaluation of Neoadjuvant Chemotherapy Response of Breast Cancer at 3.0T. Presented at the Joint ISMRM-ESMRMB Meeting, Stockholm, Sweden, May 1-7, 2010; program number 2472. 2. Chen, Jeon-Hor; Chang, Yeun-Chung; Chang, Daniel; Wang, Yi-Ting; Nie, Ke; Chang, Ruey-Feng; Nalcioglu, Orhan; Huang, Chiun-Sheng; Su, Min-Ying Lydia. Reduction of Breast Density Following Tamoxifen Treatment Evaluated by 3-D MRI. Presented at the Joint ISMRM-ESMRMB Meeting, Stockholm, Sweden, May 1-7, 2010; program number 2473. 3. Chen, Jeon-Hor; Nie, Ke; Bahri, Shadfar; Mehta, Rita S.; Hsu, Chieh-Chih; Hsu, Fei-Ting; Shih, Han-Ni; Lin, Muqing; Nalcioglu, Orhan; Su, Min-Ying Lydia. MRI Evaluation of Decrease of Breast Density in the Contralateral Normal Breast of Patients Receiving Neoadjuvant Chemotherapy. Presented at the Joint ISMRM-ESMRMB Meeting, Stockholm, Sweden, May 1-7, 2010; program number 2474. 4. Chen, J-H. The Association between Choline Concentration Measured by 1H MR Spectroscopy with Clinical Characteristics and MR Imaging Features of Breast Cancer. Presented at 95th RSNA annual meeting, Chicago, 2009, abstract number LL-BR4087-L02 5. Chen, Jeon-Hor; Hsu, F-T; Shih, H-N; Hsu, C-C; Chang, Daniel; Nie, K; Nalcioglu, Orhan; Su, M-Y. Comparison of Breast Density in the Contralateral Normal Breast of Patients with Different 11 Types of Breast Cancer Measured on MRI. in "Proc., 17th ISMRM Annual Meeting, Honolulu, Hawaii, 2009" page 2230. G. Invited Talks (Recent years) 1. Correlation of clinical characteristics and biomarkers with breast MRI/MRS. March 20, 2010. Asian-Ocean Congress of Radiology 2010, Taipei, Taiwan. KeyNote Speaker. 2. Assessment of breast cancer risk: 3D MR-based breast density vs. mammographic density. March 22, 2010. Asian-Ocean Congress of Radiology 2010, Taipei, Taiwan. KeyNote Speaker. 3. Prediction and monitoring of treatment response for breast cancer following neoadjuvant chemotherapy: evaluated with breast MRI. March 22, 2010. Asian-Ocean Congress of Radiology 2010, Taipei, Taiwan. KeyNote Speaker. 4. Response Evaluation of Breast Cancer Chemotherapy Using MR Imaging and Quantitative 1H MR Spectroscopy. September 11, 2010. Shaping Future Cancer Medicine: The 1ST Samsung Comprehensive Cancer Center Symposium, Seoul, Korea. KeyNote Speaker 5. Measurement of Breast Density and Correlation with Cancer Risk. September 10, 2010. Department of Radiology, Samsung Medical Center, Seoul, Korea. Invited Talk. 6. Breast MR Imaging and MR Spectroscopic Choline Quantification: Correlated with Biomarkers and Clinical Characteristics. September 10, 2010. Department of Radiology, Samsung Medical Center, Seoul, Korea. Invited Talk. 7. Imaging Biomarkers: Hopes and Hurdles. March 20, 2011. Annual Meeting of the Radiological Society of the Republic of China, Taichung, Taiwan. KeyNote Speaker. 8. Brief Review of Diagnosis and Management of Prostate Cancer. March 20, 2011. Annual Meeting of the Radiological Society of the Republic of China, Taichung, Taiwan. KeyNote Speaker. 9. Imaging Tumor Response: RECIST and Beyond. May 29, 2013. Department of Radiology, Taichung Veterans General Hospital, Taichung, Taiwan. 10. Breast Imaging Beyond Mammography and Ultrasonography. October 22, 2013. Radiological Society of Republic of China (RSROC), Kaoshiung, Taiwan. (to be delivered) 12